Recent advances and challenges of bispecific antibodies in solid tumors

Cancer immunotherapy has made remarkable progress in the past decade. Bispecific antibodies (BsAbs) have acquired much attention as the next generation strategy of antibody-target cancer immunotherapy, which overwhelmingly focus on T cell recruitment and dual receptors blockade. So far, BsAb drugs h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuze, Yi, Ming, Zhu, Shuangli, Wang, Haiyong, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684149/
https://www.ncbi.nlm.nih.gov/pubmed/34922633
http://dx.doi.org/10.1186/s40164-021-00250-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684149/
https://www.ncbi.nlm.nih.gov/pubmed/34922633
http://dx.doi.org/10.1186/s40164-021-00250-1

Ejemplares similares